Novo Nordisk Plans To Catch Them Young; Kicks Off DAWN Youth Program For Young Diabetics in India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Spurred by an alarming rise in the number of diabetic patients in India, Danish anti-diabetes drug maker Novo Nordisk has launched its international DAWN Youth program in the country to explore the attitudes, wishes and needs of young people with or at risk of diabetes along with their families. DAWN stands for Diabetes Attitudes Wishes and Needs and is operational in more than 30 countries
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)